EP0671929A4 - Compositions. - Google Patents

Compositions.

Info

Publication number
EP0671929A4
EP0671929A4 EP93923917A EP93923917A EP0671929A4 EP 0671929 A4 EP0671929 A4 EP 0671929A4 EP 93923917 A EP93923917 A EP 93923917A EP 93923917 A EP93923917 A EP 93923917A EP 0671929 A4 EP0671929 A4 EP 0671929A4
Authority
EP
European Patent Office
Prior art keywords
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93923917A
Other languages
German (de)
English (en)
Other versions
EP0671929A1 (fr
Inventor
Panayiotis Peri Constantinides
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0671929A1 publication Critical patent/EP0671929A1/fr
Publication of EP0671929A4 publication Critical patent/EP0671929A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP93923917A 1992-10-16 1993-10-15 Compositions. Withdrawn EP0671929A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96295692A 1992-10-16 1992-10-16
PCT/US1993/009915 WO1994008603A1 (fr) 1992-10-16 1993-10-15 Compositions
US962956 2001-09-25

Publications (2)

Publication Number Publication Date
EP0671929A1 EP0671929A1 (fr) 1995-09-20
EP0671929A4 true EP0671929A4 (fr) 1996-09-25

Family

ID=25506551

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93923917A Withdrawn EP0671929A4 (fr) 1992-10-16 1993-10-15 Compositions.

Country Status (3)

Country Link
EP (1) EP0671929A4 (fr)
JP (1) JPH08502490A (fr)
WO (1) WO1994008603A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018147A1 (fr) * 1991-04-19 1992-10-29 Affinity Biotech, Inc. Formulations de microemulsions a inversion de phase
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
TW438603B (en) * 1993-04-19 2001-06-07 Advanced Skin Res Kenkyusho Kk Microemulsion preparation containing peptide pharmaceuticals
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
AU698317B2 (en) 1995-02-25 1998-10-29 Cancer Research Technology Limited Transgenic animals as model of psoriasis
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
US5660858A (en) * 1996-04-03 1997-08-26 Research Triangle Pharmaceuticals Cyclosporin emulsions
GB9613858D0 (en) 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
CA2294032A1 (fr) * 1997-07-29 1999-02-11 Pharmacia & Upjohn Company Formulation autoemulsifiante pour composes lipophiles
KR100587551B1 (ko) 1997-12-10 2006-06-08 싸이클로스포린 테라퓨틱스 리미티드 오메가-3 지방산 오일을 함유하는 약학 조성물
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
WO1999053941A1 (fr) * 1998-04-15 1999-10-28 Shionogi & Co., Ltd. Preparations orales contenant des derives de trh
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
IE990935A1 (en) * 1999-11-08 2002-04-03 Procter & Gamble Cosmetic Compositions
KR100508695B1 (ko) * 2001-02-13 2005-08-17 한국과학기술연구원 인슐린의 경구투여용 제형과 그의 제조방법
EP2116228A1 (fr) 2001-10-19 2009-11-11 Isotechnika Inc. Nouveaux préconcentrés de microémulsion analogue de cyclosporine
RO123110B1 (ro) * 2001-12-14 2010-11-30 Jagotec Ag Formulare farmaceutică cu ciclosporină şi utilizarea acesteia
ES2314646T3 (es) 2004-03-22 2009-03-16 Solvay Pharmaceuticals Gmbh Composiciones farmaceuticas por via de productos que contienen lipasa , en particular de pancreatina, que contienen tensioactivos.
EP2438910A1 (fr) 2004-08-31 2012-04-11 Stiefel Research Australia Pty Ltd Procédé et compositions de micro-émulsion et d'émulsion submicronique
HUE031042T2 (en) 2005-07-29 2017-06-28 Abbott Laboratories Gmbh Methods for producing pancreatin powder with low viral content
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20110144010A1 (en) * 2007-06-01 2011-06-16 Novo Nordisk A/S Spontaneously Dispersible Preconcentrates Including a Peptide Drug in a Solid or Semisolid Carrier
WO2009115469A1 (fr) 2008-03-18 2009-09-24 Novo Nordisk A/S Analogues de l'insuline acylés stabilisés vis-à-vis des protéases
CA2870313A1 (fr) 2012-04-11 2013-10-17 Novo Nordisk A/S Formulations a base d'insuline
EP3030266B1 (fr) 2013-08-08 2020-10-28 Novan Inc. Compositions topiques et procédés d'utilisation de celles-ci
KR20160146669A (ko) * 2014-02-14 2016-12-21 징준 후앙 나노에멀젼 전달 시스템의 조성물
EP3177262A4 (fr) * 2014-08-08 2018-04-18 Novan Inc. Émulsions topiques
EP3423100A4 (fr) 2016-03-02 2019-10-16 Novan, Inc. Compositions destinées à traiter l'inflammation et méthodes de traitement associées
ES2886837T3 (es) 2016-12-16 2021-12-21 Novo Nordisk As Composiciones farmacéuticas que contienen insulina

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146499A (en) * 1976-09-18 1979-03-27 Rosano Henri L Method for preparing microemulsions
EP0278660A1 (fr) * 1987-02-03 1988-08-17 Stiefel Laboratories (Ireland) Limited Microémulsions
EP0387647A2 (fr) * 1989-03-13 1990-09-19 Desitin Arzneimittel GmbH Composition pharmaceutique à haute dispersion
WO1991018669A1 (fr) * 1990-06-08 1991-12-12 Affinity Biotech, Inc. Procede servant a preparer des microemulsions
WO1992018147A1 (fr) * 1991-04-19 1992-10-29 Affinity Biotech, Inc. Formulations de microemulsions a inversion de phase
WO1993002665A1 (fr) * 1991-07-26 1993-02-18 Smithkline Beecham Corporation Microemulsion huileuse
WO1993002664A1 (fr) * 1991-07-26 1993-02-18 Smithkline Beecham Corporation Micro-emulsion huileuse

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876765A (en) * 1968-05-03 1975-04-08 Choay Sa Pharmaceutical composition containing vitamin b' 12', process of making the same and method of treatment therewith

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146499A (en) * 1976-09-18 1979-03-27 Rosano Henri L Method for preparing microemulsions
EP0278660A1 (fr) * 1987-02-03 1988-08-17 Stiefel Laboratories (Ireland) Limited Microémulsions
EP0387647A2 (fr) * 1989-03-13 1990-09-19 Desitin Arzneimittel GmbH Composition pharmaceutique à haute dispersion
WO1991018669A1 (fr) * 1990-06-08 1991-12-12 Affinity Biotech, Inc. Procede servant a preparer des microemulsions
WO1992018147A1 (fr) * 1991-04-19 1992-10-29 Affinity Biotech, Inc. Formulations de microemulsions a inversion de phase
WO1993002665A1 (fr) * 1991-07-26 1993-02-18 Smithkline Beecham Corporation Microemulsion huileuse
WO1993002664A1 (fr) * 1991-07-26 1993-02-18 Smithkline Beecham Corporation Micro-emulsion huileuse

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9408603A1 *

Also Published As

Publication number Publication date
WO1994008603A1 (fr) 1994-04-28
EP0671929A1 (fr) 1995-09-20
JPH08502490A (ja) 1996-03-19

Similar Documents

Publication Publication Date Title
ZA939656B (en) Microvicidal compositions.
EP0598412A3 (fr) Composition pour la protection de la peau.
EP0621279A3 (fr) Compositions de siloxy-aluminoxane.
EP0597463A3 (en) Thermotherapiesonde.
CY2441B1 (en) Aerosol compositions.
EP0605089A3 (en) Photoresist composition.
EP0580285A3 (fr) Auto-réenclencheurs.
PL315128A1 (en) Anti-pollutant compositions
IL110665A0 (en) Erection-inducing compositions
ZA932689B (en) Disinfectant compositions.
ZA937274B (en) Detergent composition.
GB9318641D0 (en) Compositions
ZA933068B (en) Detergent composition.
GB9215772D0 (en) Compositions
GB9323313D0 (en) Clenasing compositions
EP0598335A3 (fr) Nouvelles compositions de nettoyage.
GB9213059D0 (en) Compositions
PH30815A (en) Composition.
GB9304823D0 (en) Cable-making compositions
EP0599191A3 (fr) Circuit de régulation de vitesse d'un moteur.
CY2411B1 (en) Compositions.
GB9210526D0 (en) Compositions
GB9313759D0 (en) Cementiferous compositions
GB9202656D0 (en) Compositions
ZA929387B (en) Pediculicidal compositions.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950510

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE FR GB IT LI NL

A4 Supplementary search report drawn up and despatched

Effective date: 19960807

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE FR GB IT LI NL

17Q First examination report despatched

Effective date: 19980925

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990206